Deal-making in the global pharmaceuticals sector is booming, with no signs of slowing down. 2015 promises to be a prosperous year, with deals likely to be
Write to Us
End-to-end support services across the deal cycle to global Private Equity and Venture Capital firms.
Investment opportunities screened across multiple sectors and business (start-ups to mature businesses) lifecycles.
Business due diligence exercises conducted on opportunities across different sectors and geographies.
Regular reporting and portfolio management of PE/VC firms.
PE-VC firms leverage our research expertise across the deal cycle.
- Funding environment assessment
- Macro and sector research
- Investor identification, screening and profiling
- Presentation support
- Road show presentation
- Pitchbook preparation
- Investment & private placement memoranda
- Prospectus drafting
- Sector and market studies
- Deals analysis
- Valuation multiples
- Discount/premia analysis
- Target identification and screening
- “Hot list” generation
- Company profiles
- Financial modeling & valuations
- Discounted cash flows (DCF) and market-based/relative valuation
- Precedent transactions analysis
- Comparative company analysis
- Sensitivity analysis dashboards
- Business due diligence
- Deal viability
- Market/sector study
- Reporting and presentation support
- Portfolio reporting and MIS
- Investment board presentations
- Sales and marketing support
- Strategic Initiatives
- Periodic valuation, investor communication
- Evaluating exit opportunities
- List generation and buyer screening
- Identify and shortlist (strategic) acquirer
- Strategic sale assessment
- Financial modeling and valuations
- Precedent transactions and IPO valuation
- Relative valuation
- Returns analysis
Presence Across the Deal Cycle
We support PE/VC firms across the deal cycle — from research/screening of targets, through fund raising, deal evaluation and management, portfolio management up to evaluating potential exit opportunities.
Global Research Experience
Our pool of 150+ analysts have a combined experience of 750+ man years and are well-versed in assisting PE/VC firms on a multitude of deals across all major markets.
Impactful Analysis for Investors
Our critical and relevant analysis have helped the PE/VC firms on managing and growing their portfolio companies, as well as in evaluation of exit opportunities.
|North America||75+ years of combined analyst experience in assisting boutique as well as regional private equity/venture capital firms in deals spread across 20+ sectors. Closely monitored and managed portfolios of over US$ 2 billion|
|Western Europe||50+ years of combined analyst experience in conducting market and feasibility studies, target identification, and pitchbooks|
|Africa & Middle East||100+ years of combined analyst experience in evaluating potential investment opportunities, market studies, due diligence , tracking portfolio performance, and PPM|
|Asia & South Pacific||75+ hours of combined analyst experience in the APAC region, with projects involving opportunity assessments and portfolio modelling|
Looking to increase your investment research coverage while still reducing costs?
Write to Us
© 2017, Aranca. All rights reserved.
United States | United Kingdom | China | India | Dubai | KSA